US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist

17.300
-0.040-0.23%

Close Oct 31 16:00 ET

17.300
0.0000.00%

Post 16:00 ET

809.60MMarket Cap-13675P/E (TTM)

Silence Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Silence Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 2.833M	--
--	2024/Q3	-- / 3.000M	--
--	2024/Q2	598.000K / 9.850M	--
--	2024/Q1	12.406M / 3.550M	--
Mar 13, 2024	2023/Q4	2.099M / 9.200M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 2.833M--

--2024/Q3-- / 3.000M--

--2024/Q2598.000K / 9.850M--

--2024/Q112.406M / 3.550M--

Mar 13, 20242023/Q42.099M / 9.200M--

Unlock Free Earnings Estimates

Open Account

Silence Therapeutics Earnings Reports

6-K: Report of foreign private issuer (related to financial reporting)

Aug 15 09:07 ET

6-K: Report of foreign private issuer (related to financial reporting)

May 16 14:26 ET

Silence Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 15 07:03 ET

Silence Therapeutics | 20-F: FY2023 Annual Report

Mar 13 08:58 ET

Analyst Rating

Updated: Oct 31, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall